包容成败
Lv4
520 积分
2023-11-14 加入
-
Systemic treatment for severe atopic dermatitis in children: a case series
1个月前
已完结
-
Thalidomide Responsive Recalcitrant Adult-Onset Atopic Dermatitis – Repurposing an Old Drug
1个月前
已关闭
-
Efficacy and safety of SYSA1902 versus reference ustekinumab in moderate-to-severe plaque psoriasis: A multicenter, randomized, phase III study
2个月前
已关闭
-
Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission
2个月前
已完结
-
Erythrodermic psoriasis treated with ustekinumab: An Italian multicenter retrospective analysis
2个月前
已完结
-
Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study
2个月前
已完结
-
Effectiveness, quality of life, and safety of secukinumab versus conventional systemic therapy in patients with erythrodermic psoriasis: a comparative study
3个月前
已关闭
-
Clinical Experience of Risankizumab in Patients With a History of Erythrodermic Psoriasis
3个月前
已关闭
-
The efficacy and safety of deucravacitinib compared to methotrexate, in patients with vulvar lichen planus who have failed topical therapy with potent corticosteroids: a study protocol for a single-centre double-blinded randomised controlled trial
3个月前
已完结
-
Correction: Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial
3个月前
已关闭